Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
0.0120
0.00 (0.00%)
At close: Oct 6, 2026
Trevena Market Cap
Trevena has a market cap or net worth of $11.51 thousand as of October 9, 2026. It is the 51,718th most valuable company in the world and the 7,759th biggest in the United States.
Market Cap
11.51K
Enterprise Value
n/a
Revenue
546.00K
Global Rank
Country Rank
#7,759 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from 167.27M to 11.51K, a decrease of -99.99%. That is a compound annual growth rate of -53.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 11.51K | - |
| Dec 31, 2025 | 11.51K | -99.11% |
| Dec 31, 2024 | 1.30M | -88.18% |
| Dec 29, 2023 | 10.96M | -0.67% |
| Dec 30, 2022 | 11.03M | -88.49% |
| Dec 31, 2021 | 95.83M | -71.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 16.83K |
| Vaxxinity | 12.68K |
| NovAccess Global | 12.33K |
| Scorpius Holdings | 12.23K |
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |
| GeneLink | 10.60K |
| Bio-Path Holdings | 10.06K |